Blinatumomab-Associated Elevation of Liver Enzymes

Am J Ther. 2023 Jan-Feb;30(1):e83-e84. doi: 10.1097/MJT.0000000000001348. Epub 2021 Feb 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Bispecific* / adverse effects
  • Antineoplastic Agents* / adverse effects
  • Humans
  • Liver

Substances

  • blinatumomab
  • Antineoplastic Agents
  • Antibodies, Bispecific